Abstract
Introduction
Transdermal fentanyl, an opioid used for management of marked pain, also is abused and may cause death.
Methods
We reviewed medical examiner reports of 92 decedents who had one or more fentanyl transdermal patches on their body and had fentanyl detected in their postmortem toxicology analysis.
Results
The manners of death included 40 accidents, 36 natural, 8 suicides, 5 therapeutic complications, and 3 undetermined deaths. Among the accidental fentanyl intoxication deaths, 32 of 37 involved substance abuse. The majority (95 %) of the 37 accidental deaths involving fentanyl were multi-drug intoxications. The substance abuse deaths had a mean fentanyl blood concentration (26.4 ng/ml or μg/L) that was over twice that of the natural group (11.8 ng/ml). Our analysis suggests a relationship between total patch dosage and mean postmortem fentanyl concentration up to the 100-μg/h dose.
Conclusions
The very wide and overlapping ranges of postmortem fentanyl concentrations effectively nullify the utility of correlating the dose and expected postmortem concentration for any particular death. Based on the variable relationship between dose and blood concentration, the antemortem dose cannot be reliably predicted based on the postmortem concentration. This does not, however, render the medical examiner/coroner unable to determine the cause and manner of death because the toxicology results are only one datum point among several that are considered. Although there was a weakly positive relationship between body mass index and fentanyl concentration, further research is needed to determine whether adipose tissue represents a significant depot for postmortem release of fentanyl.
Similar content being viewed by others
References
Baselt R (2004) Disposition of toxic drugs and chemicals in man, 7th edn. Biomedical Publications, Foster City, p 451
Nelson L, Schwaner R (2009) Transdermal fentanyl: pharmacology and toxicology. J Med Toxicol 5:230–241
Shibutani K, Inchiosa MA Jr, Sawada K, Bairamian M (2005) Pharmacokinetic mass of fentanyl for postoperative analgesia in lean and obese patients. Br J Anaesth 95:377–383
Gill JR, Goldfeder LB, Hirsch CS (2006) Use of “therapeutic complication” as a manner of death. J Forensic Sci 51:1127–1133
Adams VI, Flomenbaum MA, Hirsch CS (2006) Trauma and disease. In: Spitz WU (ed) Spitz and Fisher's medicolegal investigation of death. Charles C. Thomas, Springfield, pp 436–459
Krinsky CS, Lathrop SL, Crossey M, Baker G, Zumwalt R (2011) A toxicology-based review of fentanyl-related deaths in new Mexico (1986–2007). Am J Forensic Med Pathol 32:347–351
Thompson JG, Baker AM, Bracey AH, Seningen J, Kloss JS, Strobl AQ et al (2007) Fentanyl concentrations in 23 postmortem cases from the Hennepin County Medical Examiner's Office. J Forensic Sci 52:978–981
Hull MJ, Juhascik M, Mazur F, Flomenbaum MA, Behonick GS (2007) Fatalities associated with fentanyl and co-administered cocaine or opiates. J Forensic Sci 52:1383–1388
Martin TL, Woodall KL, McLellan BA (2006) Fentanyl-related deaths in Ontario, Canada: toxicological findings and circumstances of death in 112 cases (2002–2004). J Anal Toxicol 30:603–610
Smialek JE, Levine B, Chin L, Wu SC, Jenkins AJ (1994) A fentanyl epidemic in Maryland 1992. J Forensic Sci 39:159–164
Denton JS, Donoghue ER, McReynolds J, Kalelkar MB (2008) An epidemic of illicit fentanyl deaths in Cook County, Illinois: September 2005 through April 2007. J Forensic Sci 53:452–454
Henderson GL (1991) Fentanyl-related deaths: demographics, circumstances, and toxicology of 112 cases. J Forensic Sci 36:422–433
Wong SC, Curtis JA, Wingert WE (2008) Concurrent detection of heroin, fentanyl, and xylazine in seven drug-related deaths reported from the Philadelphia Medical Examiner's Office. J Forensic Sci 53:495–498
Fernando D (1991) Fentanyl-laced heroin. Jama 265:2962
Anderson DT, Muto JJ (2000) Duragesic transdermal patch: postmortem tissue distribution of fentanyl in 25 cases. J Anal Toxicol 24:627–634
Jumbelic MI (2010) Deaths with transdermal fentanyl patches. Am J Forensic Med Pathol 31:18–21
Biedrzycki OJ, Bevan D, Lucas S (2009) Fatal overdose due to prescription fentanyl patches in a patient with sickle cell/beta-thalassemia and acute chest syndrome: a case report and review of the literature. Am J Forensic Med Pathol 30:188–190
Coopman V, Cordonnier J, Pien K, Van Varenbergh D (2007) LC-MS/MS analysis of fentanyl and norfentanyl in a fatality due to application of multiple Durogesic transdermal therapeutic systems. Forensic Sci Int 169:223–227
Kuhlman JJ Jr, McCaulley R, Valouch TJ, Behonick GS (2003) Fentanyl use, misuse, and abuse: a summary of 23 postmortem cases. J Anal Toxicol 27:499–504
Tharp AM, Winecker RE, Winston DC (2004) Fatal intravenous fentanyl abuse: four cases involving extraction of fentanyl from transdermal patches. Am J Forensic Med Pathol 25:178–181
Lilleng PK, Mehlum LI, Bachs L, Morild I (2004) Deaths after intravenous misuse of transdermal fentanyl. J Forensic Sci 49:1364–1366
Thomas S, Winecker R, Pestaner JP (2008) Unusual fentanyl patch administration. Am J Forensic Med Pathol 29:162–163
Woodall KL, Martin TL, McLellan BA (2008) Oral abuse of fentanyl patches (Duragesic): seven case reports. J Forensic Sci 53:222–225
Prosser JM, Jones BE, Nelson L (2010) Complications of oral exposure to fentanyl transdermal delivery system patches. J Med Toxicol 6:443–447
Olson KN, Luckenbill K, Thompson J, Middleton O, Geiselhart R, Mills KM et al (2010) Postmortem redistribution of fentanyl in blood. Am J Clin Pathol 133:447–453
Bianchi RP (2006) Letter to the editor-comparison of fentanyl extraction from two different transdermal patches. J Forensic Sci 51:939
Jin M, Gock SB, Jannetto PJ, Jentzen JM, Wong SH (2005) Pharmacogenomics as molecular autopsy for forensic toxicology: genotyping cytochrome P450 3A4*1B and 3A5*3 for 25 fentanyl cases. J Anal Toxicol 29:590–598
Palmer RB (2010) Fentanyl in postmortem forensic toxicology. Clin Toxicol (Phila) 48:771–784
Jung BF, Reidenberg MM (2005) Interpretation of opioid levels: comparison of levels during chronic pain therapy to levels from forensic autopsies. Clin Pharmacol Ther 77:324–334
Andresen H, Gullans A, Veselinovic M, Anders S, Schmoldt A, Iwersen-Bergmann S et al (2012) Fentanyl: toxic or therapeutic? Postmortem and antemortem blood concentrations after transdermal fentanyl application. J Anal Toxicol 36:182–194
Edinboro LE, Poklis A, Trautman D, Lowry S, Backer R, Harvey CM (1997) Fatal fentanyl intoxication following excessive transdermal application. J Forensic Sci 42:741–743
Acknowledgment
We thank Dr. Charles Hirsch for his critical review of the manuscript and Dr. Elizabeth Marker for her help in identifying these cases.
Conflict of Interest
There is no outside funding of any kind used for this study and it has not been previously presented at a meeting in data or in abstract form. Lewis Nelson has served as an expert witness in cases involving transdermal fentanyl.
Author information
Authors and Affiliations
Corresponding author
Additional information
An erratum to this article is available at http://dx.doi.org/10.1007/s13181-014-0427-y.
Rights and permissions
About this article
Cite this article
Gill, J.R., Lin, P.T. & Nelson, L. Reliability of Postmortem Fentanyl Concentrations in Determining the Cause of Death. J. Med. Toxicol. 9, 34–41 (2013). https://doi.org/10.1007/s13181-012-0253-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13181-012-0253-z